Kangmei Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and medical devices in China. The company's products comprise Chinese herbal medicines, including American ginseng, notoginseng powder, salvia powder, and others. It also offers chemical drugs, such as paracetamol pseudoephedrine tablets, clarithromycin dispersible tablets, metronidazole tablets, inosine tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, and erythromycin enteric-coated tablets, as well as ranitidine hydrochloride capsules. In addition, it operates a hospital; a drug research institute that provides technical support for the U.S. pharmaceutical development; and Chinese medicine and health products stores. The company serves customers through a network of 7 regional distributors and 1019 point of sale facilities. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Puning, China.
kangmei pharmaceutical co-a
(600518:Shanghai Stock Exchange)
The Middle Section
Phone: 86 66 3291 7777
Fax: 86 66 3291 6111www.kangmei.com.cn
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for 600518.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact KANGMEI PHARMACEUTICAL CO-A, please visit www.kangmei.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.